Jens Kastrup

Medicine & Life Sciences

1. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 15%
2. Adipose Tissue 20%
3. Angina Pectoris 33%
4. Arterial Pressure 16%
5. Biomarkers 28%
6. Bone Marrow 21%
7. Bone Marrow Cells 14%
8. Brain Natriuretic Peptide 20%
9. Cell- and Tissue-Based Therapy 62%
10. Cerebrovascular Circulation 15%
11. Clarithromycin 30%
12. Coronary Artery Disease 91%
13. Coronary Disease 39%
14. Dilated Cardiomyopathy 35%
15. Electrocardiography 15%
16. Endothelins 15%
17. Granulocyte Colony-Stimulating Factor 34%
18. Heart 22%
19. Heart Failure 72%
20. Heart Transplantation 25%
21. Hematopoietic Stem Cell Mobilization 21%
22. Injections 25%
23. Insulin 17%
24. Ischemia 20%
25. Left Ventricular Function 15%
26. Leg 28%
27. Lidocaine 22%
28. Magnetic Resonance Imaging 16%
29. Mesenchymal Stem Cells 100%
30. Mortality 35%
31. Myocardial Infarction 60%
32. Myocardial Ischemia 75%
33. Myocardium 20%
34. Percutaneous Coronary Intervention 30%
35. Perfusion 31%
36. Placebos 59%
37. Positron-Emission Tomography 23%
38. Regeneration 16%
39. Rubidium-82 15%
40. Safety 17%
41. Serum 20%
42. Skin 18%
43. ST Elevation Myocardial Infarction 47%
44. Stem Cells 57%
45. Stents 15%
46. Stroke Volume 25%
47. Stromal Cells 58%
48. Therapeutics 29%
49. Vascular Endothelial Growth Factor A 34%
50. Vascular Resistance 15%